Asosiy kontentga oʻtish
Maqola

Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants

Bin TuUniversity of Chinese Academy of Sciences, Beijing 100049, ChinaHuiyuan WangShanghai Institute of Materia MedicaXinran AnUniversity of Michigan College of Pharmacy, Ann Arbor, MI 48109, USAJingkun QuSchool of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, ChinaQianqian LiShanghai Institute of Materia MedicaYanrong GaoState Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, ChinaMingjie ShiShanghai Institute of Materia MedicaHong QiuState Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, ChinaYongzhuo HuangTaizhou University, School of Advanced Study, Institute of Natural Medicine and Health Product, Taizhou 318000, China
2022en
ABI

Annotatsiya

The heparin polysaccharide nanoparticles block the interaction between heparan sulfate/S protein and inhibit the infection of both wild-type SARS-CoV-2 pseudovirus and the mutated strains through pulmonary delivery.Image 1.

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar

2 ta iqtibos0 ta foydalanilgan manba